Table 2.
List of Phase I/II clinical trials conducted to date by the Cell Factory in cooperation with clinical groups belonging to different specialties within or outside our hospital on a national basis
| Clinical protocols | Condition | Eudract number | Authorization date | Recruitment | Speciality | Number of treatedpatients | References |
|---|---|---|---|---|---|---|---|
| CD34+ expanded progenitor cells from cord blood in blood disorders | Blood disorders | Not needed (submitted before May 1, 2004) | 11/09/2005 | Completed | Hematology | 3 | 4,5 |
| CD133+ cells from BM and PB for myocardial repair | Acute myocardial infarction | Not needed (submitted before May 1, 2004) | 09/25/2003 | Completed | Cardiology | 10 | 6,7 |
| CD133+ cells for end-stage liver disease | End-stage liver disease | 2009-011783-10 | 09/14/2009 | Completed | Hepatology | 12 | 8 |
Abbreviations: BM, bone marrow; PB, peripheral blood.